Skip to main content
Arizona Watch· Daily Pulse

The Country's Overdose Deaths Fell 11%. New Mexico's Rose 32%. Arizona Barely Moved.

Washington is celebrating 18 straight months of falling overdose deaths. CDC's state numbers show the Southwest is not sharing in the decline, and meth is a big reason.

ByThe Rize NewsroomNovember 17, 20262 min readFentanyl

On Monday the White House drug office announced that U.S. overdose deaths had fallen for an 18th consecutive month, to a predicted 65,724 in the 12 months ending June 2026. That number is real, and every one of those missing deaths is someone still here. But the same CDC dataset, broken down by state, tells a story that doesn’t fit in a press release.

A national average is a story about somewhere else. In the Southwest, the overdose crisis isn’t ending. It’s changing shape.

Here is the comparison, using CDC’s provisional counts for the year ending June 2026 against the year before. Nationally, predicted deaths fell 11.3%. In New Mexico, they rose from 870 to 1,152, up about 32%, with deaths involving synthetic opioids up roughly half. In Arizona, deaths slipped from 2,904 to 2,777, a drop of about 4%, less than half the national pace. Nevada, next door, fell about 10%.

Arizona’s numbers show why the national formula doesn’t fit here. Stimulants, mostly meth, were involved in 1,602 of Arizona’s 2,777 predicted deaths. That’s 58%, and many of those deaths involved fentanyl too. Naloxone, the backbone of the national decline, reverses opioids. It does nothing for the stimulant half of the picture, and the country still has no approved medication for meth use disorder. The Arizona Public Health Association flagged the state’s divergence in June, and nothing in this release suggests it has closed. In Albuquerque, the Journal recently convened a public panel to ask the question New Mexico families have been asking for three years: why us?

For Arizona providers, the practical move this week: if your intake screens for opioids and treats stimulants as a footnote, flip the order. Ask about meth first, and ask whether the person also uses opioids, on purpose or not. Then send every patient who uses stimulants home with naloxone anyway, because the fentanyl is often already in the supply.

If you live here and you use, naloxone is still free through Arizona’s statewide pharmacy standing order and many community programs. Rize can help you find treatment that covers meth, not just opioids. The national number is falling. Out here, the people who are still dying need care that’s built for what’s actually in the supply.

Filed Under

trendspolicyArizonaOverdoseGovernment DataFentanylMethamphetaminePolysubstanceNaloxone

Keep up with the reporting.

One email each morning with the stories that put days like this in context.

A daily, no-spam briefing. Unsubscribe anytime.

Continue reading

More from this section